Company Overview
MONOPAR THERAPEUTICS
MNPRRevenue vs. Cost of Revenue
Revenue
Cost of Revenue
Total Operating Expenses vs. Operating Income
Total Operating Expenses
Operating Income
Net Income
Net Income
Revenue
—M
2025 FY
Net Income
-14M
2025 FY
Shares Outstanding
7M
2025 FY
EPS
-1.85USD
2025 FY
Company Information
SIC Code
2834
CIK Code
1645469
Exchange
Nasdaq
Location
US